Ignite Creation Date:
2025-12-24 @ 2:19 PM
Ignite Modification Date:
2026-01-21 @ 3:31 AM
Study NCT ID:
NCT00227695
Status:
COMPLETED
Last Update Posted:
2019-05-15
First Post:
2005-09-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma
Sponsor:
Swiss Cancer Institute
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lymphoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | stage I grade 1 follicular lymphoma | View |
| None | stage I grade 2 follicular lymphoma | View |
| None | stage I grade 3 follicular lymphoma | View |
| None | stage III grade 1 follicular lymphoma | View |
| None | stage III grade 2 follicular lymphoma | View |
| None | stage III grade 3 follicular lymphoma | View |
| None | stage IV grade 1 follicular lymphoma | View |
| None | stage IV grade 2 follicular lymphoma | View |
| None | stage IV grade 3 follicular lymphoma | View |
| None | contiguous stage II grade 1 follicular lymphoma | View |
| None | contiguous stage II grade 2 follicular lymphoma | View |
| None | contiguous stage II grade 3 follicular lymphoma | View |
| None | noncontiguous stage II grade 1 follicular lymphoma | View |
| None | noncontiguous stage II grade 2 follicular lymphoma | View |
| None | noncontiguous stage II grade 3 follicular lymphoma | View |
| None | recurrent grade 1 follicular lymphoma | View |
| None | recurrent grade 2 follicular lymphoma | View |
| None | recurrent grade 3 follicular lymphoma | View |